Latest On Helius Medical Technologies, Inc (HSDT):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-11 20:40 EST | News | Helius Medical Technologies GAAP EPS of -$0.09 beats by $0.02, revenue of $0.11M misses by $0.17M | N/A |  |
| 2023-05-11 20:40 EST | News | Helius Medical Technologies, Inc. (HSDT) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-03-11 00:13 EST | News | Helius Medical Technologies, Inc. (HSDT) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-03-09 17:42 EST | News | Helius stock rises on expanded approval of Neuromodulation Stimulator in Canada | N/A | |
| 2023-03-09 17:41 EST | News | Helius Medical Technologies GAAP EPS of -$0.17 misses by $0.04, revenue of $0.28M misses by $0.01M | N/A | |
| 2023-01-23 15:54 EST | News | Helius Medical projects 50% growth for annual revenues | N/A | |
| 2022-11-15 03:14 EST | News | Helius Medical Technologies, Inc. (HSDT) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-14 09:55 EST | News | Helius Medical Technologies GAAP EPS of -$0.12, revenue of $0.19M | N/A | |
| 2022-08-24 05:09 EST | News | Helius Medical Technologies: A Net-Net Meme Stock In The Making | N/A | |
| 2022-08-24 05:09 EST | News | Helius Medical adds 32% as Roth launches coverage with Buy | N/A | |
| 2022-08-16 08:51 EST | News | Helius Medical Technologies, Inc. (HSDT) CEO Dane Andreeff on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-15 16:29 EST | News | Helius Medical Technologies GAAP EPS of -$0.97 beats by $0.15, revenue of $0.12M misses by $0.24M | N/A | |
| 2022-08-05 19:17 EST | News | Helius Medical Technologies stock slides 51% after pricing $18M securities offering | N/A | |
| 2022-06-01 15:56 EST | News | Helius stock soars 38% on launch of patient program for neuromodulation stimulator therapy | N/A | |
| 2022-05-12 18:27 EST | News | Helius Medical Technologies GAAP EPS of $1.15 beats by $2.28, revenue of $0.19M beats by $0.03M | N/A | |
| 2022-05-12 18:27 EST | News | Helius Medical Technologies' (HSDT) CEO Dane Andreeff on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-03-15 04:29 EST | News | Helius Medical Technologies GAAP EPS of -$1.31 misses by $0.15, revenue of $0.26M beats by $0.16M | N/A | |
| 2022-03-15 04:28 EST | News | Helius Medical Technologies, Inc. (HSDT) CEO Dane Andreeff on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2021-12-14 15:44 EST | News | Helius Medical rallies on issuance of U.S. Patent for wireless PoNS | N/A | |
| 2021-11-11 07:11 EST | News | Helius Medical Technologies EPS misses by $0.28, misses on revenue | N/A | |
| 2021-11-11 07:11 EST | News | Helius Medical Technologies, Inc. (HSDT) CEO Dane Andreeff On Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-11-10 09:31 EST | News | Helius Medical Technologies launches stock offering | N/A | |
| 2021-11-04 10:24 EST | News | Helius Medical's PoNS device gets market authorization in Australia | N/A | |
| 2021-10-13 02:15 EST | News | Warning: HSDT is at high risk of performing badly | N/A | |
| 2021-10-06 09:28 EST | News | HSDT is at high risk of performing badly | N/A | |
| 2021-09-27 19:02 EST | News | Warning: HSDT has been downgraded to Very Bearish | N/A | |
| 2021-09-23 04:39 EST | News | Warning: HSDT has been downgraded to Very Bearish. | N/A | |
| 2021-08-17 14:48 EST | News | Helius Medical climbs on FDA Breakthrough Designation for device targeting stroke patients | N/A | |
| 2021-08-13 14:44 EST | News | Helius Medical Technologies' (HSDT) CEO Dane Andreeff on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-08-12 18:24 EST | News | Helius Medical Technologies EPS misses by $0.97, misses on revenue | N/A | |
| 2021-07-21 11:28 EST | News | Helius Medical Technologies announces new appointments to executive leadership team | N/A | |
| 2021-07-21 11:28 EST | News | Helius Medical makes CEO, CFO appointments | N/A | |
| 2021-07-21 11:13 EST | News | Helius Medical names Antonella Favit-Van Pelt as chief medical officer | N/A | |
| 2021-03-27 04:56 EST | News | Helius Medical surges on FDA authorization for neuromodulation stimulator (updated) | N/A | |
| 2021-03-12 07:51 EST | Financials | Company financials have been released. | Neutral | |
| 2021-03-11 08:17 EST | News | Helius Medical Technologies EPS misses by $1.69, beats on revenue | N/A | |
| 2021-03-11 08:17 EST | News | Helius Medical Technologies, Inc. (HSDT) CEO Dane Andreeff on Q4 2020 Results - Earnings Call Transcript | N/A | |
| 2021-01-29 01:30 EST | News | Helius Medical drops 16% after $9.6M capital raise | N/A | |
| 2021-01-19 13:29 EST | News | Helius Medical regains Nasdaq listing compliance | N/A | |
| 2021-01-05 11:58 EST | Stock Split | A stock split has occured on Jan 4, 2021 with a split factor of 1:35. | Neutral | |
| 2020-12-31 16:57 EST | News | Helius Medical Technologies announces reverse stock split | N/A | |
| 2020-11-26 20:19 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-14 20:08 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-13 01:05 EST | News | Helius Medical Technologies EPS beats by $0.01, beats on revenue | N/A | |
| 2020-11-13 01:04 EST | News | Helius Medical Technologies' (HSDT) Management on Q3 2020 Results - Earnings Call Transcript | N/A | |
| 2020-11-07 16:05 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 11:56 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-26 18:50 EST | News | Helius Medical announces $3.4M private placement | N/A | |
| 2020-10-26 16:38 EST | Insider Trade | DANE ANDREEFF has indirectly acquired of 37,363 shares. | Buy | |
| 2020-10-26 16:38 EST | Insider Trade | DANE ANDREEFF has indirectly acquired of 371,883 shares. | Buy | |
About Helius Medical Technologies, Inc (HSDT):
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator (PoNS), a medical device in Canada for the treatment of chronic balance deficit due to mild-to-moderate traumatic brain injury. Its PoNS device treats neurostimulation of cranial nerves via the tongue to restore lost function. The company is headquartered in Newtown, Pennsylvania.
General
- Name Helius Medical Technologies, Inc
- Symbol HSDT
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryMedical Devices
- Full Time Employees 19
- Last Split Factor1:35
- Last Split Date2021-01-04
- Fiscal Year EndDecember
- IPO Date2014-06-27
- Gic SectorHealth Care
- Gic GroupHealth Care Equipment & Services
- Gic IndustryHealth Care Equipment & Supplies
- Gic SubIndustryHealth Care Equipment
- Web URLhttp://heliusmedical.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 23.64
- Price/Book (Most Recent Quarter) 10.24
- Enterprise Value Revenue 45.21
View More
Financials
- Most Recent Quarter 2020-12-31
- Operating Margin -2689%
- Return on Assets -111%
- Return on Equity -282%
- Revenue 622000
- Earnings Per Share -$0.34
- Revenue Per Share $0.6
- Gross Profit 650000
- Quarterly Earnings Growth -12.7%
View More
Highlights
- Market Capitalization 21.53 million
- EBITDA -22703000
- PE Ratio -0.31
- Analyst Target Price $2.12
- Book Value Per Share $2.47
View More
Share Statistics
- Shares Outstanding 1.5 million
- Shares Float 1.48 million
- % Held by Insiders 1838%
- % Held by Institutions 17.53%
- Shares Short 31266
- Shares Short Prior Month 23772
- Short Ratio 5.33
- Short % of Float 2%
- Short % of Shares Outstanding 2%
View More
Technicals
- Beta 0.77
- 52 Week High $23.77
- 52 Week Low $8.72
- 50 Day Moving Average 14.06
- 200 Day Moving Average 14.46
View More
Dividends
- Dividend Date 2021-01-04
- ExDividend Date N/A
- Dividend Yield 0%
View More
Helius Medical Technologies, Inc (HSDT) Dividend Calendar:
HSDT's last dividend payment was made to shareholders on January 4, 2021.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Helius Medical Technologies, Inc (HSDT) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-03-10 | $190000 | -$1.77 | -$0.08 | -2112.5% |
| 2020-09-30 | 2020-11-12 | $N/A | -$2.80 | -$3.15 | 11.11% |
| 2020-06-30 | 2020-08-12 | $N/A | -$2.80 | -$4.20 | 33.33% |
| 2020-03-31 | 2020-05-07 | $207000 | -$5.25 | -$5.60 | 6.25% |
| 2019-12-31 | 2020-03-12 | $152000 | -$6.65 | -$7.35 | 9.52% |
| 2019-09-30 | 2019-11-12 | $150000 | -$7.70 | -$7.70 | 0% |
| 2019-06-30 | 2019-08-08 | $518000 | -$0.35 | -$7.88 | 95.56% |
| 2019-03-31 | 2019-05-09 | $677000 | $1.75 | -$8.93 | 119.61% |
| 2018-12-31 | 2019-03-14 | $478000 | -$7.35 | -$7.53 | 2.33% |
| 2018-09-30 | 2018-11-08 | $N/A | -$6.65 | -$8.05 | 17.39% |
| 2018-06-30 | 2018-08-09 | $N/A | -$27.30 | -$8.05 | -239.13% |
| 2018-03-31 | 2018-05-08 | $N/A | -$2.10 | ||
| 2017-12-31 | 2018-03-12 | $N/A | -$0.18 | ||
| 2017-09-30 | 2017-11-09 | $N/A | -$0.67 | ||
| 2017-06-30 | 2017-08-11 | $N/A | -$0.30 | -$0.05 | -500% |
| 2017-03-31 | 2017-04-03 | $N/A | -$0.30 | ||
| 2016-12-31 | 2016-12-31 | $N/A | -$0.35 | -$0.03 | -1066.67% |
| 2016-09-30 | 2016-11-14 | $N/A | -$7.00 | -$0.03 | -23233.33% |
| 2016-06-30 | 2016-08-15 | $N/A | -$7.00 | -$0.03 | -23233.33% |
| 2016-03-31 | 2016-06-28 | $N/A | -$5.25 | -$8.75 | 40% |
| 2015-12-31 | 2016-02-16 | $N/A | -$0.20 | -$0.20 | 0% |
| 2015-09-30 | 2015-11-16 | $N/A | $0.10 | -$0.05 | 300% |
| 2015-06-30 | 2015-08-11 | $N/A | -$0.25 | -$0.40 | 37.5% |
| 2015-03-31 | 2015-06-29 | $N/A | $0.05 | -$0.10 | 150% |
| 2014-12-31 | 2015-03-15 | $N/A | -$0.06 | -$0.05 | -20% |
| 2014-09-30 | 2014-11-15 | $N/A | -$0.04 | -$0.03 | -33.33% |
| 2014-06-30 | 2014-08-29 | $N/A | -$0.04 |
Helius Medical Technologies, Inc (HSDT) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Research Development | 827000 | N/A | N/A | 1.12 million | 1.6 million |
| Income Before Tax | -2.54 million | N/A | N/A | -4.76 million | -5.33 million |
| Selling General Administrative | 2.09 million | N/A | N/A | 2.86 million | 3.81 million |
| Gross Profit | -11000 | N/A | N/A | 106000 | -156000 |
| Ebit | -2.54 million | N/A | N/A | -3.84 million | -5.63 million |
| Operating Income | -3 million | N/A | N/A | -4 million | -5.63 million |
| Income Tax Expense | N/A | N/A | N/A | N/A | N/A |
| Total Revenue | 190000 | N/A | N/A | 207000 | 152000 |
| Cost of Revenue | 201000 | N/A | N/A | 101000 | 308000 |
| Total Other Income Expense Net | N/A | N/A | N/A | -755000 | 294000 |
| Net Income From Continuing Operations | -2.54 million | N/A | N/A | -4.76 million | -5.33 million |
| Net Income Applicable to Common Shares | -2.54 million | -3.48 million | -3.36 million | -4.76 million | -5.33 million |
Cash Flow:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Investments | N/A | N/A | N/A | N/A | N/A |
| Change to Liabilities | 296000 | -661000 | -710000 | -438000 | -1.33 million |
| Total Cash Flow from Investing Activities | -11000 | 61000 | -10000 | -509000 | -56000 |
| Net Borrowings | N/A | N/A | N/A | N/A | N/A |
| Total Cash Flow from Financial Activities | N/A | N/A | N/A | 1.49 million | N/A |
| Change to Operating Activities | 260000 | 111000 | -301000 | -859000 | 432000 |
| Change in Cash | N/A | N/A | N/A | -3.56 million | -5.29 million |
| Total Cash from Operating Activities | -2.59 million | -3.23 million | -3.75 million | -4.54 million | -5.25 million |
| Depreciation | N/A | N/A | N/A | 102000 | 42000 |
| Other Cash Flow from Investing Activities | N/A | N/A | N/A | N/A | N/A |
| Change to Inventory | N/A | N/A | N/A | 691000 | -387000 |
| Change to Account Receivables | N/A | N/A | N/A | -58000 | 166000 |
| Other Cash Flow from Financing Activities | N/A | -166000 | -340000 | -195000 | N/A |
| Change to Net Income | 269000 | 500000 | 1.89 million | 1.35 million | 1.42 million |
| Capital Expenditures | N/A | N/A | N/A | 18000 | 56000 |
Balance Sheet:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Total Liabailities | 2.68 million | N/A | N/A | 3.25 million | 4.51 million |
| Total Stockholder Equity | 3.87 million | N/A | N/A | 5.21 million | 5.84 million |
| Other Current Liabilities | 340000 | 339000 | N/A | N/A | 435000 |
| Total Assets | 6.55 million | N/A | N/A | 8.46 million | 10.35 million |
| Common Stock | 1000 | 45000 | 45000 | 38000 | 31000 |
| Other Current Assets | 735000 | N/A | N/A | N/A | N/A |
| Retained Earnings | -118.9 million | -116.37 million | -112.89 million | -109.53 million | -104.77 million |
| Other Liabilities | N/A | 217000 | 219000 | 218000 | 245000 |
| Other Assets | N/A | 18000 | 18000 | 18000 | 18000 |
| Cash | 3.33 million | N/A | N/A | 4.36 million | 5.46 million |
| Total Current Liabilities | 2.42 million | 2.57 million | N/A | 2.62 million | 3.8 million |
| Other Stockholder Equity | -1.1 million | -693000 | -521000 | -266000 | -902000 |
| Property, Plant & Equipment | 486000 | 568000 | 595000 | 1.2 million | 1.26 million |
| Total Current Assets | 4.69 million | 4.14 million | N/A | 5.88 million | 7.24 million |
| Long Term Investments | N/A | N/A | N/A | N/A | N/A |
| Net Tangible Assets | 3.87 million | 1.89 million | 5.05 million | 3.84 million | 4.01 million |
| Short Term Investments | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | N/A | N/A | N/A | N/A | N/A |
| Inventory | 389000 | 572000 | N/A | 594000 | 598000 |
| Accounts Payable | 2.08 million | 720000 | N/A | 1.11 million | 1.68 million |
Helius Medical Technologies, Inc (HSDT) Chart:
Helius Medical Technologies, Inc (HSDT) News:
Below you will find a list of latest news for Helius Medical Technologies, Inc (HSDT) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Helius Medical Technologies, Inc (HSDT) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-19 | 1 | 0 | CALL | 0 | 0 | 523.81 | TRUE | 0 | 0 |
| 2025-12-19 | 2.5 | 1.1 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-12-19 | 4 | 0.35 | CALL | 0 | 120 | 193.33 | FALSE | 0 | 0 |
| 2025-12-19 | 5 | 0.07 | CALL | 103 | 2706 | 192.5 | FALSE | -0.03 | -0.3 |
| 2025-12-19 | 6 | 0.13 | CALL | 0 | 39 | 352.87 | FALSE | 0 | 0 |
| 2025-12-19 | 7.5 | 0.35 | CALL | 0 | 712 | 728.19 | FALSE | 0 | 0 |
| 2025-12-19 | 9 | 0.05 | CALL | 0 | 5 | 0 | FALSE | 0 | 0 |
| 2025-12-19 | 10 | 0 | CALL | 0 | 0 | 1323.78 | FALSE | 0 | 0 |
| 2025-12-19 | 12.5 | 0.25 | CALL | 0 | 25 | 513.51 | FALSE | 0 | 0 |
| 2025-12-19 | 15 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-12-19 | 17.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-12-19 | 20 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-12-19 | 22.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-12-19 | 25 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-12-19 | 30 | 0.05 | CALL | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2025-12-19 | 1 | 0.05 | PUT | 0 | 146 | 590.84 | FALSE | 0 | 0 |
| 2025-12-19 | 2.5 | 0.03 | PUT | 40 | 1011 | 175.6 | FALSE | 0.03 | 0 |
| 2025-12-19 | 4 | 0.35 | PUT | 0 | 18 | 742.32 | TRUE | 0 | 0 |
| 2025-12-19 | 5 | 1.23 | PUT | 0 | 357 | 538.9 | TRUE | 0 | 0 |
| 2025-12-19 | 6 | 0 | PUT | 0 | 0 | 202.25 | TRUE | 0 | 0 |
| 2025-12-19 | 7.5 | 3.46 | PUT | 0 | 300 | 267.28 | TRUE | 0 | 0 |
| 2025-12-19 | 9 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-12-19 | 10 | 6.2 | PUT | 0 | 21 | 346.11 | TRUE | 0 | 0 |
| 2025-12-19 | 12.5 | 8.5 | PUT | 0 | 90 | 404.59 | TRUE | 0 | 0 |
| 2025-12-19 | 15 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-12-19 | 17.5 | 12.54 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-12-19 | 20 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-12-19 | 22.5 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-12-19 | 25 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-12-19 | 30 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-01-16 | 1 | 0 | CALL | 0 | 0 | 242.21 | TRUE | 0 | 0 |
| 2026-01-16 | 2.5 | 0 | CALL | 0 | 0 | 977.88 | TRUE | 0 | 0 |
| 2026-01-16 | 4 | 1.3 | CALL | 0 | 13 | 343.51 | FALSE | 0 | 0 |
| 2026-01-16 | 5 | 0.4 | CALL | 0 | 133 | 689.05 | FALSE | 0 | 0 |
| 2026-01-16 | 6 | 0.25 | CALL | 0 | 3006 | 205.9 | FALSE | 0 | 0 |
| 2026-01-16 | 7.5 | 0.14 | CALL | 0 | 527 | 188.18 | FALSE | 0 | 0 |
| 2026-01-16 | 9 | 0 | CALL | 0 | 0 | 727.1 | FALSE | 0 | 0 |
| 2026-01-16 | 10 | 0.14 | CALL | 0 | 296 | 250.29 | FALSE | 0 | 0 |
| 2026-01-16 | 12.5 | 0.9 | CALL | 0 | 503 | 696.68 | FALSE | 0 | 0 |
| 2026-01-16 | 15 | 0.1 | CALL | 0 | 129 | 288.69 | FALSE | 0 | 0 |
| 2026-01-16 | 17.5 | 3.2 | CALL | 0 | 3 | 812.27 | FALSE | 0 | 0 |
| 2026-01-16 | 20 | 0.05 | CALL | 0 | 588 | 830.66 | FALSE | 0 | 0 |
| 2026-01-16 | 22.5 | 3.51 | CALL | 0 | 11 | 846.51 | FALSE | 0 | 0 |
| 2026-01-16 | 25 | 0.31 | CALL | 0 | 570 | 587.62 | FALSE | 0 | 0 |
| 2026-01-16 | 30 | 0.22 | CALL | 0 | 93 | 883.88 | FALSE | 0 | 0 |
| 2026-01-16 | 35 | 0.4 | CALL | 0 | 25 | 903.2 | FALSE | 0 | 0 |
| 2026-01-16 | 1 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 2.5 | 0.2 | PUT | 0 | 3 | 848.22 | FALSE | 0 | 0 |
| 2026-01-16 | 4 | 0.78 | PUT | 0 | 5 | 800.06 | TRUE | 0 | 0 |
| 2026-01-16 | 5 | 1.35 | PUT | 0 | 20 | 170.62 | TRUE | 0 | 0 |
| 2026-01-16 | 6 | 0 | PUT | 0 | 0 | 221.44 | TRUE | 0 | 0 |
| 2026-01-16 | 7.5 | 3.53 | PUT | 0 | 300 | 251.67 | TRUE | 0 | 0 |
| 2026-01-16 | 9 | 0 | PUT | 0 | 0 | 290.4 | TRUE | 0 | 0 |
| 2026-01-16 | 10 | 4.6 | PUT | 0 | 22 | 294.69 | TRUE | 0 | 0 |
| 2026-01-16 | 12.5 | 9 | PUT | 0 | 173 | 300.11 | TRUE | 0 | 0 |
| 2026-01-16 | 15 | 0 | PUT | 0 | 0 | 343.6 | TRUE | 0 | 0 |
| 2026-01-16 | 17.5 | 0 | PUT | 0 | 0 | 366.46 | TRUE | 0 | 0 |
| 2026-01-16 | 20 | 13.2 | PUT | 0 | 881 | 385.87 | TRUE | 0 | 0 |
| 2026-01-16 | 22.5 | 12.4 | PUT | 0 | 8 | 386 | TRUE | 0 | 0 |
| 2026-01-16 | 25 | 0 | PUT | 0 | 0 | 361.15 | TRUE | 0 | 0 |
| 2026-01-16 | 30 | 0 | PUT | 0 | 0 | 386.06 | TRUE | 0 | 0 |
| 2026-01-16 | 35 | 0 | PUT | 0 | 0 | 428.49 | TRUE | 0 | 0 |
| 2026-04-17 | 1 | 0 | CALL | 0 | 0 | 119.74 | TRUE | 0 | 0 |
| 2026-04-17 | 2.5 | 2.2 | CALL | 0 | 46 | 0 | TRUE | 0 | 0 |
| 2026-04-17 | 4 | 1.51 | CALL | 0 | 34 | 205.04 | FALSE | 0 | 0 |
| 2026-04-17 | 5 | 0.75 | CALL | 0 | 301 | 172.84 | FALSE | 0 | 0 |
| 2026-04-17 | 6 | 0.9 | CALL | 0 | 69 | 137.1 | FALSE | 0 | 0 |
| 2026-04-17 | 7.5 | 0.7 | CALL | 0 | 270 | 235.36 | FALSE | 0 | 0 |
| 2026-04-17 | 9 | 0.4 | CALL | 0 | 22 | 446.48 | FALSE | 0 | 0 |
| 2026-04-17 | 10 | 0.45 | CALL | 0 | 288 | 208.72 | FALSE | 0 | 0 |
| 2026-04-17 | 12.5 | 0.55 | CALL | 0 | 148 | 421.2 | FALSE | 0 | 0 |
| 2026-04-17 | 15 | 1 | CALL | 0 | 458 | 468.07 | FALSE | 0 | 0 |
| 2026-04-17 | 17.5 | 0.48 | CALL | 0 | 548 | 470.89 | FALSE | 0 | 0 |
| 2026-04-17 | 20 | 2.5 | CALL | 0 | 55 | 480.47 | FALSE | 0 | 0 |
| 2026-04-17 | 22.5 | 3.23 | CALL | 0 | 13 | 480.6 | FALSE | 0 | 0 |
| 2026-04-17 | 25 | 2.8 | CALL | 0 | 17 | 487.89 | FALSE | 0 | 0 |
| 2026-04-17 | 30 | 0.1 | CALL | 0 | 49 | 492.38 | FALSE | 0 | 0 |
| 2026-04-17 | 35 | 3.9 | CALL | 0 | 1 | 502.57 | FALSE | 0 | 0 |
| 2026-04-17 | 1 | 0.13 | PUT | 0 | 20 | 0 | FALSE | 0 | 0 |
| 2026-04-17 | 2.5 | 0.45 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2026-04-17 | 4 | 0 | PUT | 0 | 0 | 563.05 | TRUE | 0 | 0 |
| 2026-04-17 | 5 | 2.25 | PUT | 1 | 220 | 151.64 | TRUE | 2.25 | 0 |
| 2026-04-17 | 6 | 0 | PUT | 0 | 0 | 161.95 | TRUE | 0 | 0 |
| 2026-04-17 | 7.5 | 4 | PUT | 0 | 22 | 210.69 | TRUE | 0 | 0 |
| 2026-04-17 | 9 | 5.8 | PUT | 0 | 9 | 187.24 | TRUE | 0 | 0 |
| 2026-04-17 | 10 | 5.25 | PUT | 0 | 7 | 191.35 | TRUE | 0 | 0 |
| 2026-04-17 | 12.5 | 5.19 | PUT | 0 | 56 | 206 | TRUE | 0 | 0 |
| 2026-04-17 | 15 | 7.4 | PUT | 0 | 10 | 242.2 | TRUE | 0 | 0 |
| 2026-04-17 | 17.5 | 14.5 | PUT | 0 | 0 | 215.37 | TRUE | 0 | 0 |
| 2026-04-17 | 20 | 15.45 | PUT | 0 | 30 | 234.55 | TRUE | 0 | 0 |
| 2026-04-17 | 22.5 | 0 | PUT | 0 | 0 | 244.9 | TRUE | 0 | 0 |
| 2026-04-17 | 25 | 0 | PUT | 0 | 0 | 230.24 | TRUE | 0 | 0 |
| 2026-04-17 | 30 | 0 | PUT | 0 | 0 | 254.54 | TRUE | 0 | 0 |
| 2026-04-17 | 35 | 31.3 | PUT | 3 | 3 | 268.03 | TRUE | 31.3 | 0 |
| 2026-07-17 | 1 | 2.95 | CALL | 2 | 0 | 228.57 | TRUE | 2.95 | 0 |
| 2026-07-17 | 2 | 0 | CALL | 0 | 0 | 153.56 | TRUE | 0 | 0 |
| 2026-07-17 | 3 | 1.55 | CALL | 10 | 0 | 125.38 | TRUE | 1.55 | 0 |
| 2026-07-17 | 4 | 1.65 | CALL | 0 | 7 | 465.17 | FALSE | 0 | 0 |
| 2026-07-17 | 5 | 0 | CALL | 0 | 0 | 440.38 | FALSE | 0 | 0 |
| 2026-07-17 | 6 | 0 | CALL | 0 | 0 | 396.37 | FALSE | 0 | 0 |
| 2026-07-17 | 7 | 0 | CALL | 0 | 0 | 374.35 | FALSE | 0 | 0 |
| 2026-07-17 | 8 | 0 | CALL | 0 | 0 | 202.44 | FALSE | 0 | 0 |
| 2026-07-17 | 1 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2026-07-17 | 2 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2026-07-17 | 3 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2026-07-17 | 4 | 1.9 | PUT | 0 | 1 | 160.22 | TRUE | 0 | 0 |
| 2026-07-17 | 5 | 0 | PUT | 0 | 0 | 160.36 | TRUE | 0 | 0 |
| 2026-07-17 | 6 | 0 | PUT | 0 | 0 | 147.1 | TRUE | 0 | 0 |
| 2026-07-17 | 7 | 0 | PUT | 0 | 0 | 149.42 | TRUE | 0 | 0 |
| 2026-07-17 | 8 | 0 | PUT | 0 | 0 | 151.62 | TRUE | 0 | 0 |
Latest HSDT Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 2:53 PM EST | 200 | $1.61 |
| Jun 13, 2022 5:55 PM EST | 500 | $1.56 |
Helius Medical Technologies, Inc (HSDT) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-07-02 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1610853/000119312520186797/0001193125-20-186797-index.htm |
| 2020-09-23 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1610853/000000000020008949/0000000000-20-008949-index.htm |
| 2020-03-30 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1610853/000090571820000330/0000905718-20-000330-index.htm |
| 2020-03-30 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1610853/000091957420002634/0000919574-20-002634-index.htm |
| 2020-03-18 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1610853/000119312520076644/0001193125-20-076644-index.htm |
| 2020-03-18 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1610853/000119312520077331/0001193125-20-077331-index.htm |
| 2020-04-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610853/000119312520108654/0001193125-20-108654-index.htm |
| 2020-04-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610853/000119312520114242/0001193125-20-114242-index.htm |
| 2020-04-28 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1610853/000119312520121683/0001193125-20-121683-index.htm |
| 2020-04-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610853/000119312520127759/0001193125-20-127759-index.htm |
| 2020-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610853/000119312520136362/0001193125-20-136362-index.htm |
| 2020-05-11 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1610853/000119312520139219/0001193125-20-139219-index.htm |
| 2020-05-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610853/000119312520139927/0001193125-20-139927-index.htm |
| 2020-06-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610853/000119312520167183/0001193125-20-167183-index.htm |
| 2020-07-02 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1610853/000119312520186797/0001193125-20-186797-index.htm |
| 2020-07-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610853/000119312520192265/0001193125-20-192265-index.htm |
| 2020-09-15 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1610853/000119312520246308/0001193125-20-246308-index.htm |
| 2020-09-23 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1610853/000119312520252131/0001193125-20-252131-index.htm |
| 2020-09-28 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1610853/000119312520255579/0001193125-20-255579-index.htm |
| 2020-11-05 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1610853/000119312520287016/0001193125-20-287016-index.htm |
| 2020-02-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610853/000120919120009885/0001209191-20-009885-index.htm |
| 2020-02-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610853/000120919120009886/0001209191-20-009886-index.htm |
| 2020-03-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610853/000120919120014443/0001209191-20-014443-index.htm |
| 2020-03-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610853/000120919120014445/0001209191-20-014445-index.htm |
| 2020-03-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610853/000120919120019389/0001209191-20-019389-index.htm |
| 2020-03-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610853/000120919120019394/0001209191-20-019394-index.htm |
| 2020-03-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610853/000120919120020579/0001209191-20-020579-index.htm |
| 2020-04-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610853/000120919120023567/0001209191-20-023567-index.htm |
| 2020-04-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610853/000120919120023569/0001209191-20-023569-index.htm |
| 2020-04-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610853/000120919120024746/0001209191-20-024746-index.htm |
| 2020-04-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610853/000120919120024748/0001209191-20-024748-index.htm |
| 2020-04-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610853/000120919120025152/0001209191-20-025152-index.htm |
| 2020-05-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610853/000120919120026455/0001209191-20-026455-index.htm |
| 2020-05-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610853/000120919120026456/0001209191-20-026456-index.htm |
| 2020-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610853/000120919120029577/0001209191-20-029577-index.htm |
| 2020-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610853/000120919120029581/0001209191-20-029581-index.htm |
| 2020-05-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610853/000120919120030046/0001209191-20-030046-index.htm |
| 2020-05-19 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610853/000120919120030349/0001209191-20-030349-index.htm |
| 2020-05-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610853/000120919120030507/0001209191-20-030507-index.htm |
| 2020-06-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610853/000120919120033153/0001209191-20-033153-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610853/000120919120036341/0001209191-20-036341-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610853/000120919120036349/0001209191-20-036349-index.htm |
| 2020-06-12 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610853/000120919120036361/0001209191-20-036361-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610853/000120919120036454/0001209191-20-036454-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610853/000120919120036457/0001209191-20-036457-index.htm |
| 2020-06-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610853/000120919120036949/0001209191-20-036949-index.htm |
| 2020-06-16 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610853/000120919120036988/0001209191-20-036988-index.htm |
| 2020-06-16 | 3/A | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610853/000120919120036993/0001209191-20-036993-index.htm |
| 2020-06-16 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610853/000120919120037012/0001209191-20-037012-index.htm |
| 2020-06-16 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610853/000120919120037015/0001209191-20-037015-index.htm |
| 2020-06-16 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610853/000120919120037028/0001209191-20-037028-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610853/000120919120040096/0001209191-20-040096-index.htm |
| 2020-07-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610853/000120919120042598/0001209191-20-042598-index.htm |
| 2020-08-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610853/000120919120044399/0001209191-20-044399-index.htm |
| 2020-10-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610853/000120919120054124/0001209191-20-054124-index.htm |
| 2020-10-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610853/000120919120054127/0001209191-20-054127-index.htm |
| 2020-10-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610853/000120919120055810/0001209191-20-055810-index.htm |
| 2020-10-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1610853/000120919120055814/0001209191-20-055814-index.htm |
| 2020-03-18 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1610853/000153561020000081/0001535610-20-000081-index.htm |
| 2020-02-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610853/000156459020005320/0001564590-20-005320-index.htm |
| 2020-03-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610853/000156459020007966/0001564590-20-007966-index.htm |
| 2020-03-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610853/000156459020010456/0001564590-20-010456-index.htm |
| 2020-03-12 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1610853/000156459020010496/0001564590-20-010496-index.htm |
| 2020-03-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610853/000156459020011626/0001564590-20-011626-index.htm |
| 2020-03-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610853/000156459020012315/0001564590-20-012315-index.htm |
| 2020-03-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610853/000156459020013609/0001564590-20-013609-index.htm |
| 2020-05-11 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1610853/000156459020024198/0001564590-20-024198-index.htm |
| 2020-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610853/000156459020037233/0001564590-20-037233-index.htm |
| 2020-08-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610853/000156459020039684/0001564590-20-039684-index.htm |
| 2020-08-12 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1610853/000156459020039685/0001564590-20-039685-index.htm |
| 2020-08-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610853/000156459020041093/0001564590-20-041093-index.htm |
| 2020-09-08 | 10-K/A | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1610853/000156459020042819/0001564590-20-042819-index.htm |
| 2020-09-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610853/000156459020043012/0001564590-20-043012-index.htm |
| 2020-10-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610853/000156459020046019/0001564590-20-046019-index.htm |
| 2020-10-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610853/000156459020046799/0001564590-20-046799-index.htm |
| 2020-10-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610853/000156459020047107/0001564590-20-047107-index.htm |
| 2020-10-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610853/000156459020047638/0001564590-20-047638-index.htm |
| 2020-10-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1610853/000156459020047881/0001564590-20-047881-index.htm |
| 2020-09-25 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1610853/999999999520002583/9999999995-20-002583-index.htm |
Helius Medical Technologies, Inc (HSDT) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Helius Medical Technologies, Inc (HSDT). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 1838%Institutional Ownership: 1753%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-06-30 | Joyce N LaViscount | CFO and COO | Buy | 6,429.00 | 0.43 | 2,764.47 | 100,347.00 | https://www.sec.gov/Archives/edgar/data/1610853/000120919120040096/0001209191-20-040096-index.htm |
| 2020-07-15 | Joyce N LaViscount | CFO and COO | Buy | 5,312.00 | 0.52 | 2,745.24 | 105,659.00 | https://www.sec.gov/Archives/edgar/data/1610853/000120919120042598/0001209191-20-042598-index.htm |
| 2020-07-31 | Joyce N LaViscount | CFO and COO | Buy | 4,946.00 | 0.56 | 2,745.03 | 110,605.00 | https://www.sec.gov/Archives/edgar/data/1610853/000120919120044399/0001209191-20-044399-index.htm |
| 2020-10-21 | DANE ANDREEFF | Interim President and CEO | Buy | 638,182.00 | 0.46 | 294,776.27 | 1,420,525.00 | https://www.sec.gov/Archives/edgar/data/1610853/000120919120055810/0001209191-20-055810-index.htm |
| 2020-10-21 | Joyce N LaViscount | CFO and COO | Buy | 38,138.00 | 0.46 | 17,615.94 | 148,743.00 | https://www.sec.gov/Archives/edgar/data/1610853/000120919120055814/0001209191-20-055814-index.htm |
| 2020-05-13 | DANE ANDREEFF | Director | Buy | 17,038.00 | 0.57 | 9,711.66 | 149,042.00 | https://www.sec.gov/Archives/edgar/data/1610853/000120919120029581/0001209191-20-029581-index.htm |
| 2020-05-15 | DANE ANDREEFF | Director | Buy | 11,359.00 | 0.56 | 6,361.04 | 166,080.00 | https://www.sec.gov/Archives/edgar/data/1610853/000120919120030507/0001209191-20-030507-index.htm |
| 2020-05-13 | DANE ANDREEFF | Director | Buy | 4,578.00 | 0.57 | 2,609.46 | 17,004.00 | https://www.sec.gov/Archives/edgar/data/1610853/000120919120029581/0001209191-20-029581-index.htm |
| 2020-05-15 | DANE ANDREEFF | Director | Buy | 3,052.00 | 0.56 | 1,709.12 | 21,582.00 | https://www.sec.gov/Archives/edgar/data/1610853/000120919120030507/0001209191-20-030507-index.htm |
| 2020-10-21 | DANE ANDREEFF | Interim President and CEO | Buy | 134,873.00 | 0.46 | 62,297.84 | 300,953.00 | https://www.sec.gov/Archives/edgar/data/1610853/000120919120055810/0001209191-20-055810-index.htm |
| 2020-05-13 | DANE ANDREEFF | Director | Buy | 47,430.00 | 0.57 | 27,035.10 | 396,529.00 | https://www.sec.gov/Archives/edgar/data/1610853/000120919120029581/0001209191-20-029581-index.htm |
| 2020-02-14 | Philippe Deschamps | President and CEO | Buy | 4,704.00 | 0.85 | 3,998.40 | 41,711.00 | https://www.sec.gov/Archives/edgar/data/1610853/000120919120009885/0001209191-20-009885-index.htm |
| 2020-02-14 | Joyce N LaViscount | CFO and COO | Buy | 3,229.00 | 0.85 | 2,744.65 | 43,516.00 | https://www.sec.gov/Archives/edgar/data/1610853/000120919120009886/0001209191-20-009886-index.htm |
| 2020-05-15 | DANE ANDREEFF | Director | Buy | 31,620.00 | 0.56 | 17,707.20 | 443,959.00 | https://www.sec.gov/Archives/edgar/data/1610853/000120919120030507/0001209191-20-030507-index.htm |
| 2020-02-28 | Philippe Deschamps | President and CEO | Buy | 4,394.00 | 0.91 | 3,998.54 | 46,105.00 | https://www.sec.gov/Archives/edgar/data/1610853/000120919120014445/0001209191-20-014445-index.htm |
| 2020-02-28 | Joyce N LaViscount | CFO and COO | Buy | 3,016.00 | 0.91 | 2,744.56 | 46,532.00 | https://www.sec.gov/Archives/edgar/data/1610853/000120919120014443/0001209191-20-014443-index.htm |
| 2020-03-13 | Joyce N LaViscount | CFO and COO | Buy | 5,841.00 | 0.47 | 2,745.27 | 52,373.00 | https://www.sec.gov/Archives/edgar/data/1610853/000120919120019394/0001209191-20-019394-index.htm |
| 2020-03-13 | Philippe Deschamps | President and CEO | Buy | 8,507.00 | 0.47 | 3,998.29 | 54,612.00 | https://www.sec.gov/Archives/edgar/data/1610853/000120919120019389/0001209191-20-019389-index.htm |
| 2020-10-21 | DANE ANDREEFF | Interim President and CEO | Buy | 37,363.00 | 0.46 | 17,257.97 | 58,945.00 | https://www.sec.gov/Archives/edgar/data/1610853/000120919120055810/0001209191-20-055810-index.htm |
| 2020-03-31 | Joyce N LaViscount | CFO and COO | Buy | 8,319.00 | 0.33 | 2,745.27 | 60,692.00 | https://www.sec.gov/Archives/edgar/data/1610853/000120919120023569/0001209191-20-023569-index.htm |
| 2020-03-31 | Philippe Deschamps | President and CEO | Buy | 12,117.00 | 0.33 | 3,998.61 | 66,729.00 | https://www.sec.gov/Archives/edgar/data/1610853/000120919120023567/0001209191-20-023567-index.htm |
| 2020-05-13 | DANE ANDREEFF | Director | Buy | 80,954.00 | 0.57 | 46,143.78 | 701,389.00 | https://www.sec.gov/Archives/edgar/data/1610853/000120919120029581/0001209191-20-029581-index.htm |
| 2020-04-15 | Joyce N LaViscount | CFO and COO | Buy | 10,167.00 | 0.27 | 2,745.09 | 70,859.00 | https://www.sec.gov/Archives/edgar/data/1610853/000120919120024748/0001209191-20-024748-index.htm |
| 2020-04-30 | Joyce N LaViscount | CFO and COO | Buy | 6,399.00 | 0.43 | 2,751.57 | 77,258.00 | https://www.sec.gov/Archives/edgar/data/1610853/000120919120026456/0001209191-20-026456-index.htm |
| 2020-05-15 | DANE ANDREEFF | Director | Buy | 53,969.00 | 0.56 | 30,222.64 | 782,343.00 | https://www.sec.gov/Archives/edgar/data/1610853/000120919120030507/0001209191-20-030507-index.htm |
| 2020-04-15 | Philippe Deschamps | President and CEO | Buy | 14,809.00 | 0.27 | 3,998.43 | 81,538.00 | https://www.sec.gov/Archives/edgar/data/1610853/000120919120024746/0001209191-20-024746-index.htm |
| 2020-10-21 | DANE ANDREEFF | Interim President and CEO | Buy | 371,883.00 | 0.46 | 171,772.76 | 815,842.00 | https://www.sec.gov/Archives/edgar/data/1610853/000120919120055810/0001209191-20-055810-index.htm |
| 2020-05-15 | Joyce N LaViscount | CFO and COO | Buy | 5,501.00 | 0.50 | 2,750.50 | 82,759.00 | https://www.sec.gov/Archives/edgar/data/1610853/000120919120030046/0001209191-20-030046-index.htm |
| 2020-05-29 | Joyce N LaViscount | CFO and COO | Buy | 5,557.00 | 0.49 | 2,722.93 | 88,316.00 | https://www.sec.gov/Archives/edgar/data/1610853/000120919120033153/0001209191-20-033153-index.htm |
| 2020-04-30 | Philippe Deschamps | President and CEO | Buy | 9,320.00 | 0.43 | 4,007.60 | 90,858.00 | https://www.sec.gov/Archives/edgar/data/1610853/000120919120026455/0001209191-20-026455-index.htm |
| 2020-06-15 | Joyce N LaViscount | CFO and COO | Buy | 5,602.00 | 0.49 | 2,744.98 | 93,918.00 | https://www.sec.gov/Archives/edgar/data/1610853/000120919120036949/0001209191-20-036949-index.htm |